|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
HUNAG,PO-WEN | Huang,Chuan-sheng | Huang Chuan Sheng | (07)555-0864 | 4F., No.693, Mingcheng 3Rd., Gushan DistKaohsiung City 804 Taiwan (R.O.C) | 2011/04/29 | |||
Agent for litigious and non-litigious matters |
Tel of Agent for litigious and non-litigious matters |
Address of Agent for litigious and non-litigious matters |
||||||
HUNAG,PO-WEN | 07-5550864 | 4F., No.693, Mingcheng 3Rd., Gushan Dist | ||||||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Ma Kuang is the first to adopt scientifically-formulated Chinese herbal medicines in Singapore, customized to suit individual’s physical state and ailments, making treatment more effective and reliable hence raising the standard of TCM to be equivalent of it’s scientific Western counterpart. We collaborate with reputable suppliers to offer superior and innovative medicines and products. All our healthcare products and medicines are tested and ertified by the Ministry of Health in Singapore. |
Market Information ( 2023/12/08 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
4.608 | 35.20 | 34.85 | 34.85 | -0.15 | 8 | 1,943 | 0 | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2023/12/08) |
TPEx measures adopted (2023/12/08) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
![]() |
![]() |
![]() |